DRUG DESCRIPTION. LEVEMIRÂ® (insulin detemir [rDNA origin] injection) is a sterile solution of insulin detemir for use as a subcutaneous injection. Insulin detemir is a long-acting (up to 24-hour duration of action) recombinant human insulin analog. LEVEMIRÂ® is produced by a process that includes expression of recombinant DNA in Saccharomyces cerevisiae followed by chemical modification.
The UV Index is a linear scale, with higher values representing a greater risk of sunburn (which is correlated with other health risks) due to UV exposure. An index of 0 corresponds to zero UV radiation, as is essentially the case at night.
UV can also be measured as an irradiance, the incident power divided by the receptor surface area in watts per square metre (W m -2). Biological effectiveness of UV UV-induced biological effects depend on the wavelengths of the radiation emitted by the source.